These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 27634052)
1. A systematic review of prenatal screening for congenital heart disease by fetal electrocardiography. Verdurmen KM; Eijsvoogel NB; Lempersz C; Vullings R; Schroer C; van Laar JO; Oei SG Int J Gynaecol Obstet; 2016 Nov; 135(2):129-134. PubMed ID: 27634052 [TBL] [Abstract][Full Text] [Related]
2. Normal ranges for fetal electrocardiogram values for the healthy fetus of 18-24 weeks of gestation: a prospective cohort study. Verdurmen KMJ; Lempersz C; Vullings R; Schroer C; Delhaas T; van Laar JOEH; Oei SG BMC Pregnancy Childbirth; 2016 Aug; 16():227. PubMed ID: 27531050 [TBL] [Abstract][Full Text] [Related]
3. The standardized 12-lead fetal electrocardiogram of the healthy fetus in mid-pregnancy: A cross-sectional study. Lempersz C; van Laar JO; Clur SB; Verdurmen KM; Warmerdam GJ; van der Post J; Blom NA; Delhaas T; Oei SG; Vullings R PLoS One; 2020; 15(4):e0232606. PubMed ID: 32353083 [TBL] [Abstract][Full Text] [Related]
4. Fetal Electrocardiogram Extraction and Analysis Using Adaptive Noise Cancellation and Wavelet Transformation Techniques. Sutha P; Jayanthi VE J Med Syst; 2017 Dec; 42(1):21. PubMed ID: 29222728 [TBL] [Abstract][Full Text] [Related]
6. Systematic review and meta-analysis of the performance of second-trimester screening for prenatal detection of congenital heart defects. van Velzen CL; Ket JCF; van de Ven PM; Blom NA; Haak MC Int J Gynaecol Obstet; 2018 Feb; 140(2):137-145. PubMed ID: 29094357 [TBL] [Abstract][Full Text] [Related]
7. Utility of cardiac monitoring in fetuses at risk for congenital heart block: the PR Interval and Dexamethasone Evaluation (PRIDE) prospective study. Friedman DM; Kim MY; Copel JA; Davis C; Phoon CK; Glickstein JS; Buyon JP; Circulation; 2008 Jan; 117(4):485-93. PubMed ID: 18195175 [TBL] [Abstract][Full Text] [Related]
8. Electrocardiographic intervals in foetuses with CHD. Yilmaz B; Narayan HK; Wilpers A; Wiess C; Fifer WP; Williams IA Cardiol Young; 2016 Jan; 26(1):84-9. PubMed ID: 25599806 [TBL] [Abstract][Full Text] [Related]
9. Prenatal diagnosis of congenital heart disease: A review of current knowledge. Bravo-Valenzuela NJ; Peixoto AB; Araujo Júnior E Indian Heart J; 2018; 70(1):150-164. PubMed ID: 29455772 [TBL] [Abstract][Full Text] [Related]
10. Fetal Tricuspid Regurgitation in the First Trimester as a Screening Marker for Congenital Heart Defects: Systematic Review and Meta-Analysis. Scala C; Morlando M; Familiari A; Leone Roberti Maggiore U; Ferrero S; D'Antonio F; Khalil A Fetal Diagn Ther; 2017; 42(1):1-8. PubMed ID: 28482343 [TBL] [Abstract][Full Text] [Related]
19. [Clinical value of genome-wide high resolution chromosomal microarray analysis in etiological study of fetuses with congenital heart defects]. Wu X; Fu F; Li R; Pan M; Han J; Zhen L; Yang X; Zhang Y; Li F; Liao C Zhonghua Fu Chan Ke Za Zhi; 2014 Dec; 49(12):893-8. PubMed ID: 25608988 [TBL] [Abstract][Full Text] [Related]
20. Maternal hyperoxygenation: A potential therapy for congenital heart disease in the fetuses? A systematic review of the current literature. Co-Vu J; Lopez-Colon D; Vyas HV; Weiner N; DeGroff C Echocardiography; 2017 Dec; 34(12):1822-1833. PubMed ID: 29287137 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]